Prosecution Insights
Last updated: August 17, 2026

Examiner: BOICE, JAMES EDWARD

Tech Center 3700 • Art Units: 3681 3792 3795

This examiner grants 76% of resolved cases

Performance Statistics

76.5%
Allow Rate
+6.5% vs TC avg
183
Total Applications
+9.8%
Interview Lift
996
Avg Prosecution Days
Based on 132 resolved cases, 2023–2026

Rejection Statute Breakdown

0.5%
§101 Eligibility
21.0%
§102 Novelty
58.5%
§103 Obviousness
17.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18968253 ELEVATOR COMPONENTS FOR MEDICAL DEVICES Non-Final OA Boston Scientific Scimed, Inc.
18955410 SUCTION VALVE FOR AN ENDOSCOPE Non-Final OA Boston Scientific Scimed, Inc.
18909296 DEVICES, SYSTEMS, AND METHODS TO SUPPLY FLUIDS TO AN ENDOSCOPE Non-Final OA Boston Scientific Scimed, Inc.
18485026 MEDICAL DEVICE TRACKING SYSTEMS AND METHODS OF USING THE SAME Non-Final OA Boston Scientific Scimed, Inc.
18977999 ENDOSCOPE SYSTEM, NON-TRANSITORY COMPUTER READABLE MEDIUM, AND METHOD Non-Final OA Sony Group Corporation
17497876 SYSTEMS AND METHODS FOR MITIGATING FOGGING IN ENDOSCOPIC IMAGING Non-Final OA Stryker Corporation
18641035 SYSTEMS AND METHODS FOR GENERATING IMAGES OF A SELECTED IMAGING PLANE USING A FORWARD-FACING IMAGING ARRAY Non-Final OA INTUITIVE SURGICAL OPERATIONS, INC.
18252435 TENSION CONTROL OF NONSYMMETRICAL FLEXIBLE DEVICES Non-Final OA INTUITIVE SURGICAL OPERATIONS, INC.
18929542 ENDOSCOPE SYSTEM AND METHOD OF OPERATING THE SAME Non-Final OA FUJIFILM Corporation
18740526 ENDOSCOPE TREATMENT TOOL, ENDOSCOPE DEVICE, AND TREATMENT METHOD Final Rejection FUJIFILM Corporation
19015611 DYNAMIC FLEXIBLE SCOPE DRIVE AND METHODS OF USING SAME Non-Final OA AURIS HEALTH, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month